Krause, R., Warren, C.M., Simmons, J.D., Rebeiro, P.F., Maruri, F., Karim, F., Sterling, T.R., Koethe, J.R., Leslie, A. and van der Heijden, Y.F., 2023. Failure to decrease HbA1c levels following TB treatment is associated with elevated Th1/Th17 CD4+ responses. Frontiers in Immunology, 14, p.1151528.
van der Heijden, Y.F., Maruri, F., Blackman, A., Morrison, R., Guo, Y. and Sterling, T.R., 2023. Mycobacterium tuberculosis gene expression associated with fluoroquinolone resistance and efflux pump inhibition. The Journal of Infectious Diseases, p.jiad112.
Chimoyi, L., Kufa, T., Matsena-Zingoni, Z., Marx, F., Otwombe, K., Musenge, E. and Charalambous, S., 2023. Small area analysis of HIV viral load suppression patterns in a high priority district (2012–2016), South Africa. PLOS Global Public Health, 3(3), p.e0001728.
Beesham, I., Parikh, U.M., Mellors, J.W., Joseph Davey, D.L., Heffron, R., Palanee-Phillips, T., Bosman, S.L., Beksinska, M., Smit, J., Ahmed, K. and Makkan, H., 2022. High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study. JAIDS Journal of Acquired Immune Deficiency Syndromes, 91(2), pp.130-137.
Murphy, J.P., Kgowedi, S., Coetzee, L., Maluleke, V., Letswalo, D., Mongwenyana, C., Subrayen, P., Charalambous, S., Mvusi, L., Dlamini, S. and Martinson, N., 2022. Assessment of facility-based tuberculosis data quality in an integrated HIV/TB database in three South African districts. PLOS Global Public Health, 2(9), p.e0000312.
Musekiwa, A., Silinda, P., Bamogo, A., Twabi, H.S., Mohammed, M., Batidzirai, J.M., Matsena Zingoni, Z., Singini, G.C., Moyo, M., Mchunu, N.N. and Ekwomadu, T.I., 2022. Prevalence and factors associated with self-reported HIV testing among adolescent girls and young women in Rwanda: evidence from 2019/20 Rwanda Demographic and Health Survey. BMC Public Health, 22(1), pp.1-9.
Moodie, Z., Dintwe, O., Sawant, S., Grove, D., Huang, Y., Janes, H., Heptinstall, J., Laher Omar, F., Cohen, K., De Rosa, S.C. and Zhang, L., 2022. Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk. The Journal of Infectious Diseases
Makkan, H., Maenetje, P., Chetty-Makkan, C.M., Muchiri, E., Latka, M.H., Edward, V.A., Price, M.A., Omosa-Manyonyi, G. and Lindan, C., 2022. Attitudes Toward Gender-Based Violence Among Sexually Active Adult Men at High Risk for HIV in Rustenburg, South Africa. American journal of men's health, 16(3), p.15579883221106331.
